Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Bridgewater, New Jersey 08807


Purpose:

The primary objective is to assess the activity of nerispirdine in improving the ability to walk, in patients with multiple sclerosis (MS). Secondary objectives: - To assess other measures of walking ability, tiredness, and lower limb muscular strength, spasticity, clinical assessment by subject and clinical assessment of change by the Study Investigator - To assess the safety and tolerance of nerispirdine - To evaluate the pharmacokinetics (PK) parameters of nerispirdine


Criteria:

Inclusion Criteria: - Clinically definite MS (according to McDonald criteria), Exclusion Criteria: - Multiple sclerosis exacerbation or clinical relapse within 6-month prior to the screening visit. - Subject who is not able to complete two trials of a timed 25 foot walk, with or without an assisted device, - Patients without valid V1, V2, and V4 T25-FW measurements are not eligible for randomization. - Female patients who are either pregnant or breastfeeding. Other protocol-defined inclusion/exclusion criteria may apply.


NCT ID:

NCT00811902


Primary Contact:

Study Director
Clinical Sciences & Operations
Sanofi-Aventis


Backup Contact:

N/A


Location Contact:

Bridgewater, New Jersey 08807
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.